U.S. Markets close in 5 hrs 15 mins
  • S&P 500

    -33.35 (-0.75%)
  • Dow 30

    -193.69 (-0.56%)
  • Nasdaq

    -122.70 (-0.81%)
  • Russell 2000

    -5.11 (-0.23%)
  • Crude Oil

    -1.05 (-1.45%)
  • Gold

    -6.30 (-0.36%)
  • Silver

    -0.40 (-1.74%)

    -0.0022 (-0.1880%)
  • 10-Yr Bond

    +0.0510 (+3.83%)
  • Vix

    +0.94 (+5.03%)

    -0.0042 (-0.3053%)

    +0.2320 (+0.2114%)

    -301.61 (-0.63%)
  • CMC Crypto 200

    -20.46 (-1.67%)
  • FTSE 100

    -39.44 (-0.56%)
  • Nikkei 225

    +176.71 (+0.58%)

Medical Marijuana and the Opioid Crisis: Can It Have an Impact?

Dublin, Jan. 13, 2020 (GLOBE NEWSWIRE) -- The "Medical Marijuana and the Opioid Crisis" report has been added to ResearchAndMarkets.com's offering.

Marijuana from the Cannabis plant is classified as a psychoactive drug used for medical or recreational purposes. Although it has been used for decades, in the U.S., it is still illegal under federal law to use and possess marijuana.

Nevertheless, at the state level, policies regarding the medical and recreational use of Cannabis vary greatly, and in many states conflict significantly with federal law. For example, as early as 1996, California voters passed Proposition 215, making the Golden State the first to allow for the medical use of marijuana.

As of today, 34 states, the District of Columbia, Guam, Puerto Rico, and the U.S. Virgin Islands have approved a comprehensive, publicly available medical marijuana/Cannabis programs.

Indeed, although Cannabis use as the recreational drug may be controversial, there is no doubt that this plant has important medical properties that can be beneficial for certain medical conditions.

Pain relief is one of the properties attributed to marijuana. Consequently, in the wake of the opioid crisis, many see this plant as a solution for opioid addiction. Nevertheless, the pathway to substitute marijuana for opioids as a painkiller is not so simple.

This report covers:

  • A short introduction to what is medical marijuana: definition and main active compounds (cannabinoids)

  • Current uses of medical marijuana: epilepsy, inflammation, especially as pain medication for cancer patients

  • Approved products on the market containing medical marijuana/cannabinoids

  • Current manufacturers of medical marijuana

  • Information on medical marijuana in the drug development market (examples of some companies)

  • How medical marijuana is different from opioids and how/if it helps with the crisis

  • Effect of legislation on medical marijuana sector: potential trends in the medical marijuana market, new opportunities, and products

Key Topics Covered:

Chapter 1 Medical Marijuana and the Opioid Crisis

  • What Are Cannabinoids and How Are They Related to Medical Marijuana?

  • FDA-Approved Cannabinoids

  • Medical Marijuana Manufacturers Market

  • What Are Opioids and How Do They Differ from Cannabinoids?

  • Can Medical Marijuana Solve the Opioid Crisis?

  • Current Cannabinoids-Based Drug Developers

  • Summary and Future Trends in the Medical Marijuana/ Cannabinoids Market

Chapter 2 References

List of Tables
Table 1: Examples of Companies Manufacturing Medical Marijuana
Table 2: Examples of Companies Working on Cannabinoids in Drug Development

List of Figures
Figure 1: THC and Its Effect on the Endocannabinoid System
Figure 2: Effect of Opioid on Pain Relief in the Nervous System
Figure 3: Statistics for Opioid-Related Deaths, 1999-2017
Figure 4: Total Number of Publications Related to Marijuana and Pain, 2012-2018

For more information about this report visit https://www.researchandmarkets.com/r/knlirm

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900